Sequential administration of new agents (NAs) after docetaxel (DOC) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Impact of disease control (DC) duration in second line on the subsequent line outcomes
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Umberto Basso Gaetano Facchini Ugo De Giorgi Daniele Santini |
| Publication date | January 10, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |